Abstract

The lack of robust methods to preserve, purify and in vitro maintain the phenotype of the human liver’s highly specialized parenchymal and non-parenchymal cell types importantly hampers their exploitation for the development of research and clinical applications. There is in this regard a growing interest in the use of tissue-specific extracellular matrix (ECM) to provide cells with an in vitro environment that more closely resembles that of the native tissue. In the present study, we have developed a method that allows for the isolation and downstream application of the human liver’s main cell types from cryopreserved material. We also isolated and solubilized human liver ECM (HL-ECM), analyzed its peptidomic and proteomic composition by mass spectrometry and evaluated its interest for the culture of distinct primary human liver cells. Our analysis of the HL-ECM revealed proteomic diversity, type 1 collagen abundance and partial loss of integrity following solubilization. Solubilized HL-ECM was evaluated either as a coating or as a medium supplement for the culture of human primary hepatocytes, hepatic stellate cells and liver sinusoidal endothelial cells. Whereas the solubilized HL-ECM was suitable for cell culture, its impact on the phenotype and/or functionality of the human liver cells was limited. Our study provides a first detailed characterization of solubilized HL-ECM and a first report of its influence on the culture of distinct human primary liver cells.

Highlights

  • The liver fulfills a myriad of vital functions due to its complex assembly of highly specialized parenchymal and non-parenchymal liver cells

  • To assess whether the different major liver cell populations can be isolated from the cryopreserved liver cell fractions, we adapted a protocol previously applied to fresh human liver material [22] and identified the purified cell populations by a comparative analysis of the expression of cell-type specific genes by qPCR: albumin (ALB), cytochrome P450 3A4 (CYP3A4), hepatocyte nuclear factor 4α (HNF4A) and glucose-6-phosphatase catalytic subunit (G6PC) for HEPs, cytoglobin (CYGB) for hepatic stellate cells (HSCs), NO synthase 3 (NOS3) as a pan endothelial cells (ECs) marker, stabilin 1/2 (STAB1/2), Fcγ receptor 2b (FCGR2B) and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) for liver sinusoidal endothelial cells (LSECs) and CD163 for MPs [14,16,22,27,28]

  • We found by dosing the protein content retained on Tissue culture plastic (TCP) following coating with different concentrations of solubilized HL-extracellular matrix (ECM) that a plateau in protein adsorption started at 50 μg/mL

Read more

Summary

Introduction

The liver fulfills a myriad of vital functions due to its complex assembly of highly specialized parenchymal and non-parenchymal liver cells. Whereas the cryopreservation of freshly isolated HEPs has been the subject of numerous studies [6], the cryopreservation of the NPF, prior to and in view of its further processing for the purification of the different non-parenchymal liver cell types, has been poorly studied Another important hurdle constitutes the rapid loss of the specific phenotype of human primary liver cells in vitro. It is well-known that, upon in vitro culture, HEPs rapidly lose their polarity and metabolic properties [7,8], HSCs undergo an activation process during which they rapidly lose their retinoid-containing lipid droplets and acquire a fibrogenic, myofibroblast-like phenotype [9,10], and LSECs lose their fenestrations and sinusoidal-specific transcriptomic signature [11,12]. The composition of human liver-specific ECM (HL-ECM) and its potential impact on the function and phenotype of the main human liver cell populations has not yet been investigated

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call